Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Eros Int'l. Files For IPO Of Up To $250 Mln - Quick Facts

Eros International Plc (EROS.L) filed for an initial public offering of its stock Friday with the U.S. Securities and Exchange Commission, with the proposed maximum offering price of $250 million. The company intends plans to list on the New York Stock Exchange under the ticker, "EROS."

Also, the company plans to use the net proceeds from this offering to fund new co-productions and acquisitions, including catalog content, to grow our digital and other distribution channels and for general corporate purposes. The offering is being made through Deutsche Bank Securities, BofA Merrill Lynch, Citigroup, and UBS Investment Bank.

Click here to receive FREE breaking news email alerts for Eros International and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks may move to the downside in early trading on Thursday, adding to the modest losses posted in the previous session. The major index futures are currently pointing to a modestly lower open for the markets, with the Dow futures down by 30 points. Germany's unemployment declined unexpectedly in October, suggesting an improvement in the labor market conditions despite weak economic developments. The number of people out of work decreased by 22,000 to 2.887 million in October, data from the Federal Labor Agency revealed Thursday. Economists had forecast an increase of 4,000. Economic confidence in the eurozone picked up in October from a 10-month low, with broad based improvement across sectors, the results of a survey by the European Commission showed Thursday. The economic confidence index rose unexpectedly to 100.7 in October from 99.9 in the prior month. The score was expected to fall to 99.7.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.